The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition. (Q39677763)
Jump to navigation
Jump to search
scientific article published on 20 July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition. |
scientific article published on 20 July 2010 |
Statements
The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition (English)
Ichiro Nakachi
Katsuhiko Naoki
Kenzo Soejima
Ichiro Kawada
Hideo Watanabe
Hiroyuki Yasuda
Sohei Nakayama
Ryosuke Satomi
Shinnosuke Ikemura
Hideki Terai
Akitoshi Ishizaka